Schedule 13G ownership disclosure

Praxis Precision Medicines Inc

Common Stock · CUSIP: 74006W207

Event date: 2025-05-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • JANUS HENDERSON GROUP PLC

    Shares: 2,300,231 · Class: 11.3%

  • Janus Henderson Biotech Innovation Master Fund Ltd

    Shares: 1,122,115 · Class: 5.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001274173-25-000185
Form type
SCHEDULE 13G/A
Filer
Janus Henderson Group Ltd.
CIK
CIK 1274173
Filed
Jun 06, 2025
Reporting period
May 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub